The Board of Investment (BoI) has approved 56.4 billion baht worth of new medical and biotechnological investment projects as part of a move to make Thailand a medical industry hub in Asean.
Up to 209 projects were granted tax privileges between 2018 and September 2020. Most of them, 129 projects valued at 30.8 billion baht, are related to medical businesses.
Coming second are 51 projects, worth 25.4 billion baht, in biotechnology, followed by 26 scientific laboratory projects, worth 1.9 billion baht.
BoI secretary-general Duangjai Asawachintachit attributed the high numbers to the government’s emphasis on the medical industry, which is one of 12 targeted S-curve industries.
The Covid-19 outbreak has also sped up medical investments in the country.
“The medical industry continues to expand due to growing demand for medical equipment and medicines in the global…
